The molecular signature of prostate cancer

The use of cDNA microarray screening is enabling more accurate analysis of prostate tissue for signs of abnormality.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the UK a man's average life time risk of developing prostate cancer is one in 13. That translates into 21,000 diagnoses each year, and the disease will kill 10,000 of these men. Yet a number of treatment options exist if an accurate diagnosis can be made early enough.

Now with the identification of two new molecular markers for prostate cancer, scientists may be on the verge of developing a more accurate diagnosis and prognosis than the current prostate specific antigen (PSA) test. The research is reported in this week's Nature by researchers from the University of Michigan Medical School.

"At present, the PSA test is a useful tool in diagnosis but it is completely unsatisfactory as a screening tool", said Chris Hiley, Senior Information Officer at The Prostate Cancer Charity. PSA tests can give false positive results and there is a lack of clear evidence of any benefit from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Susan Aldridge

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide